Association between MMP2 gene polymorphisms and dilated cardiomyopathy in a Chinese Han population

Shiyang Li1, Xiaobin Zeng1, Shihai Wang1

  • 1Division of Cardiology, Panzhihua Central Hospital, Panzhihua, China.

ESC Heart Failure
|March 3, 2023
PubMed
Abstract

Insights

Genetic variations in the MMP2 gene are linked to dilated cardiomyopathy (DCM) susceptibility and outcomes in the Chinese Han population. Specifically, the rs243865 polymorphism affects DCM risk and prognosis, potentially through altered gene expression.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Epidemiology

Background:

  • Dilated cardiomyopathy (DCM) is a common heart condition with unclear pathogenesis.
  • Matrix metalloproteinase 2 (MMP2) plays a role in cardiovascular diseases.
  • The association of MMP2 gene polymorphisms with DCM remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of MMP2 gene polymorphisms in the susceptibility and prognosis of DCM.
  • To explore the functional mechanism of MMP2 gene variants in DCM.

Main Methods:

  • Genotyping of three MMP2 promoter polymorphisms (rs243865, rs2285052, rs2285053) in 600 DCM patients and 700 controls.
  • Survival analysis for prognosis in a subset of patients.
  • Luciferase reporter assays and mRNA expression analysis for functional studies.

Main Results:

  • The rs243865-C allele was more frequent in DCM patients (P=0.001) and associated with DCM susceptibility.
  • The rs243865-C allele correlated with poor prognosis in DCM patients (HR=2.0, P=0.017).
  • Functional analysis showed rs243865-C allele enhances MMP2 expression by facilitating ZNF354C binding.

Conclusions:

  • MMP2 gene polymorphisms, particularly rs243865, are associated with DCM susceptibility and prognosis in the Chinese Han population.
  • The rs243865 polymorphism influences DCM risk and progression through altered MMP2 gene expression.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
15
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.4K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.8K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
27
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22